CANLI
Yükleniyor Veriler getiriliyor…
/ Makaleler / Scopus Detay
Scopus YÖKSİS ISSN Eşleşti SJR Q3

Increased endothelial dysfunction and insulin resistance in patients with klinefelter syndrome

Endocrine Metabolic and Immune Disorders Drug Targets · Ocak 2018

Özet
Background and Objective: Patients with Klinefelter Syndrome (KS) have increased cardiometabolic risk however the pathogenesis is not clear. We investigated the presence of endothelial dysfunction, insulin resistance and inflammation in an unconfounded population of KS. Methods: A total of 32 patients with KS (mean age 21.59 ± 1.66 years) and 33 healthy control subjects (mean age: 22.15 ± 1.03 years) were enrolled. The demographic parameters, Asymmetric dimethylarginine (ADMA), homeostatic model assessment of insulin resistance (HOMA-IR) index and high-sensitivity C-reactive protein (hs-CRP) levels were measured. Results: The patients had higher Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), insulin, HOMA-IR and ADMA levels (p < 0.001 for all) and lower High Density Lipoprotein Cholesterol (HDL-C) and total testosterone levels (p=0.002 and p<0.001, respectively), compared to the healthy controls. Total testosterone levels were significantly negatively correlated to ADMA (r =-0.479, p < 0,001), hs-CRP (r =-0.291, p = 0.034) and positively correlated to HDL-C (r = 0.429, p = 0.001) levels. The multivariate analysis has shown that total testosterone (β =-0.412, p = 0.001) and TG (β = 0.332, p = 0.009) levels were the significant independent determinants of the plasma ADMA levels. Conclusion: The results of the present study show that endothelial dysfunction and insulin resistance are prevalent even in the very young subjects with KS, who have no metabolic or cardiac problems at present. Also, hypogonadism seems to play an important role for increased cardiometabolic risk in patients with KS.
9 atıf Ocak 2018 DOI
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 3 kaydı bulundu.
Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade
2017 ISSN: 18715303 SCI-Expanded
Doç. Dr. KADRİ MURAT GÜRSES →
Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade
2017 ISSN: 18715303 SCI-Expanded Q4
Doç. Dr. MUHAMMED ULVİ YALÇIN →
Anti-Saccharomyces Cerevisiae as Unusual Antibody in Autoimmune Polyglandular Syndrome Type III: A Case Report
2019 ISSN: 1871-5303 SCI-Expanded Q3
Dr. Öğr. Üyesi AHMET GÖRGEL →

Makale Bilgileri

Toplam Atıf 9 atıf · Scopus
ISSN18715303
Yayın TarihiOcak 2018
Cilt / Sayfa18 · 401-406

Kurumlar

Gülhane Eğitim ve Araştırma Hastanesi
Ankara Turkey
Selahattin Eyyubi Public Hospital
Diyarbakir Turkey

Havuzumuzdaki Atıflar 0

Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 9.

Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi (ISSN Eşleşmesi)
Endocrine, Metabolic and Immune Disorders - Drug Targets
Q3
SJR Skoru0,552
H-Index69
YayıncıBentham Science Publishers
ÜlkeUnited Arab Emirates
Endocrinology, Diabetes and Metabolism (Q3)
Immunology and Allergy (Q3)
Dergi sayfasına git

Metrikler

9
Atıf